PHILADELPHIA, Feb. 5, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM ) ("Carisma" or the "Company"), a leader in macrophage-focused therapeutics, today ...

Carisma Therapeutics (CARM) has filed for up to 3,730,608 share offering by selling stockholders.

Investing.com – U.S. stocks were mixed after the close on Friday, as gains in the Financials, Utilities and Healthcare sectors led shares higher while losses in the Oil & Gas, ...

Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced ...

After hours: February 7 at 5:29:48 PM EST Loading Chart for CARM ...

After hours: February 7 at 7:41:17 p.m. EST ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.